AMARILLO BIOSCIENCES, INC. International Competitive Benchmarks and Financial Gap Analysis (Financial Performance Series) by ICON Group Ltd.

Cover of: AMARILLO BIOSCIENCES, INC. | ICON Group Ltd.

Published by Icon Group International .

Written in English

Read online

Subjects:

  • General,
  • Financial Analysis,
  • Statistical Analysis,
  • Forecasting,
  • Company Study.,
  • Business / Economics / Finance

Book details

The Physical Object
FormatRing-bound
Number of Pages24
ID Numbers
Open LibraryOL10839640M
ISBN 100597354871
ISBN 109780597354878

Download AMARILLO BIOSCIENCES, INC.

Amarillo Biosciences, Inc. (ABI) Amarillo, Texas, US. Amarillo Biosciences, Inc. (ABI), is a diversified healthcare company engaged in the discovery and development of novel biopharmaceuticals, technologically innovative medical treatments, and.

Stock analysis for Amarillo Biosciences Inc (AMAR:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company ees: 2. q: amarillo biosciences inc May. 17, at p.m.

ET on Edgar Online - (EDG = 10Q, 10K) Amarillo Biosciences Inc (AMAR) President, CEO &. Amarillo Biosciences Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View AMAR financial statements in ees: 6. Amarillo Biosciences Inc (OTCMKTS:AMAR) posted its earnings results on Wednesday, November, 14th.

The company reported ($) earnings per share (EPS) for the quarter. The firm had revenue of $ million for the quarter. Amarillo Biosciences had a negative return on equity of % and a negative net margin of 12,%. Amarillo Biosciences, Inc. is engaged in the business of biopharmaceutical research and development.

The Company develops biologics for the treatment of human and animal diseases. The Company's focus is research aimed at the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia and other indications using.

JOSEPH M. CUMMINS has been Chairman, President and Chief Executive Officer of Amarillo Biosciences, Inc., since August Dr. Cummins was Chairman of the Board, Amarillo Cell Culture Co., Inc.

Find real-time AMAR - Amarillo Biosciences Inc stock quotes, company profile, news and forecasts from CNN Business. Peg Ratio (TTM) is a widely used stock evaluation measure.

Find the latest Peg Ratio (TTM) for Amarillo Biosciences Inc. (AMAR). Amarillo Biosciences, Inc. engages in developing biologics for the treatment of human and animal diseases.

It focuses on research aimed at the treatment of human disease indications, particularly. Description. Amarillo Biosciences Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low dose.

Stock analysis for Amarillo Biosciences Inc (AMARD) including stock price, stock chart, company news, key statistics, fundamentals and company ees: 4.

Amarillo Biosciences, Inc. (AMAR) Related Stocks - discover similar stocks, compare dividends and return. Compare momentum and price performance. Amarillo Biosciences, Inc. is engaged in the business of biopharmaceutical research and development.

The Company develops biologics for the treatment of human and animal diseases. The Company's. Amarillo Biosciences, Inc. (the "Company” or “ABI”) is a Texas corporation formed in engaged in developing biologics for the treatment of human and animal diseases.

Find out all the key statistics for AMARILLO BIOSCIENCES (AMAR), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. Get directions, reviews and information for Amarillo Biosciences Inc in Amarillo, TX. Amarillo Biosciences Inc SW 9th Ave Amarillo TX Reviews () Website.

Book Hotels, Flights, & Rental Cars; Relaunch tutorial hints NEW. Share or Embed Map. AMAR: Amarillo Biosciences Inc. Detailed Estimate. Get the latest Detailed Estimate from Zacks Investment Research. AMAR has a ROC (Joel Greenblatt) % of ,% as of today(). In depth view into Amarillo Biosciences ROC (Joel Greenblatt) % 1/5.

Amarillo Biosciences, Inc. was incorporated in June in the State of Texas under the name of Amarillo Cell Culture Company, Incorporated.

In Maywe changed our name to Amarillo Biosciences, Inc. Our principal executive offices are located at Business Park Drive, Amarillo, Texas Our Telephone number is () Description: Amarillo Biosciences Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered.

Company Name: Amarillo Biosciences Inc., Stock Symbol: AMAR, Industry: Biotechs, Total Posts:Last Post: 1/10/ PM. Amarillo Biosciences, Inc. (ABI) (OTCBB: AMAR) today issued the following Progress Report: Hepatitis C: CytoPharm, Inc., ABI's strategic partner in Taiwan is funding a Phase 2 clinical trial of patients with chronic hepatitis C virus of the end of Octoberpatients have already been enrolled with full enrollment expected by early.

Get directions, reviews and information for Amarillo Biosciences, Inc in Amarillo, TX. Amarillo Biosciences, Inc Business Park Dr Amarillo TX Reviews () Website. Menu & Reservations Make Reservations.

Order Online Tickets Tickets See Availability Location: Business Park Dr, Amarillo,TX. Year on year Amarillo Biosciences Inc 's revenues fell % from k to k. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of m to a larger loss of m.

Amarillo Biosciences Inc's Current Key Valuation Ratios, PE, PB, PCF, PS, compare to Biotechnology & Drugs Industry and Healthcare Sector. Amarillo Biosciences, Inc. engages in the discovery and development of pharmaceutical and biotech products. It operates through the following divisions: Pharmaceutical, Medical and Consumer.

The company was founded by Joseph M. Cummins in June and is headquartered in Amarillo, TX. Find tb testing in Amarillo, TX on Yellowbook. Get reviews and contact details for each business including videos, opening hours and more. Amarillo Biosciences Inc. Sw 9th Ave.

Amarillo, TX Map () Send Email Clinical, medical & diagnostic laboratories. Website; Quick Info. Amarillo Biosciences, Inc. has identified certain goals for its future business development, and wishes to share this information with both its shareholders and the general public.

ABI recognizes. Amarillo Biosciences, Inc. is a U.S. biotechnology firm operating in global partnership with the Hayashibara Group, which also holds 7% of Amarillo Biosciences shares and has provided over $18 million in loans, grants and equity investments.

The company valuation of Amarillo Biosciences Inc. according to these metrics is way below the market valuation of its peer group. The P/Earnings NTM ratio of Amarillo Biosciences Inc.

is significantly lower than the average of its sector (Pharmaceuticals): Get Amarillo Biosciences Inc (AMAR:OTCPK) real-time stock quotes, news and financial information from CNBC. Amarillo Biosciences is based out of Amarillo.

Amarillo Biosci develops biologics for the treatment of human and animal diseases. The company focuses on the use of low-dose oral natural human interferon alpha for the treatment of Sjogren's syndrome, Behcet's disease, fibromyalgia, idiopathic pulmonary fibrosis and oral warts in HIV-positive isdom has at least Location: AMARILLO BIOSCIENCES INC, Comparing the results to its competitors, Amarillo Biosciences Inc reported Total Revenue decrease in the 4 quarter year on year by %, faster than overall decrease of Amarillo Biosciences Inc's competitors by %, recorded in the same quarter.

Amarillo Biosciences, Inc. (the "Company” or “ABI”) is a Texas corporation formed in engaged in developing biologics for the treatment of human and animal diseases. Our current focus is research aimed at the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using.

Full Profile of AMAR (Amarillo Biosciences Inc.): OTC Market Cap: M | Industry: Health Care/Life Sciences Amarillo Biosciences, Inc. engages in developing biologics for the treatment of human and animal diseases. It focuses on research aimed at the treatment of human disease indications, particularly influenza, hepatitis C.

AMAR stock forecast Our latest prediction for Amarillo Biosciences, Inc.'s stock price was made on the April 7, when the stock price was at $. In the short term (2weeks), AMAR's stock price should outperform the market by %.During that period the price should oscillate between % and +%.

In the medium term (3months), AMAR's. AMARILLO BIOSCIENCES INC (AMAR:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT.

Amarillo Biosciences, Inc. is engaged in developing biologics for the treatment of human and animal diseases. See what employees say it's like to work at Amarillo Biosciences. Salaries, reviews, and more - all posted by employees working at Amarillo Biosciences.

Amarillo Biosciences Inc (AMAR) latest news, insider trading and hedge fund ownership data provided by Insider Monkey. AMAR stock rating and analysis - Amarillo Biosciences: a summary of key financial strength and profitability metrics.

Home Homepage Membership Levels Membership Data Coverage Complete Stock List Founder's Message The book Value Investing Forum Podcast Free Trial.Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Amarillo Biosciences Inc. (AMAR) had Net Income of $M for the most recently reported fiscal quarter, ending Amarillo Biosciences, Inc. is a U.S. biotechnology firm operating in global partnership with the Hayashibara Group, which also holds twelve of Amarillo .

2814 views Friday, November 6, 2020